HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

887.023

-27.221-2.98%

Number of Gainers:3

Number of Losers:14

Number of Flat:- -

PE:- -

High:930.232

Open:914.556

Low:882.498

Close:914.244

Volume:327.70M

Turnover:2.64B

Market Cap:600.05B

Float Cap:495.41B

Loading ...

Sino Biopharmaceutical Stock Slides 1.3% in Hong Kong, Underperforms Competitors

JD Health International Stock Rises 1.3% in Hong Kong

Healthcare Shows Resilience! Pharma ETF Huabao (562050) Rises Against the Market, Livzon Pharmaceutical Group Hits Limit Up! Medical Devices Show Localized Strength, Mindray and United Imaging Advance Together

Fosun Pharma Spends HK$1.0805 Million to Repurchase 62,000 Shares on September 25

Lazard Asset Management LLC Trims 738,800 Shares in Sinopharm (01099) at Approximately HK$15.1 Per Share

FMR LLC Trims Sinopharm Stake by 732,400 Shares at About HK$15.01 Each

JD Health International Stock Sheds 2.0% in Hong Kong

Regulator Clarifies Insurers' Hong Kong Stock Connect ETF Investment Rules; Crealights' Southbound Stake Rises to 4.2%

CSPC Pharmaceutical Says Phase III Trial of Becotatug Achieves Positive Topline Results

CSPC Pharma's Phase III Trial of Lung Cancer Drug Combo Achieves Positive Topline Results

MT Newswires Live

CSPC Pharma's JMT101 Combined with Osimertinib Achieves Positive Topline Results in Phase III Trial for First-Line Treatment of EGFR ex20ins NSCLC

CSPC Pharmaceutical - Phase Iii Trial of Becotatug (Jmt101) with Osimertinib Achieves Positive Topline Results

THOMSON REUTERS

Dizal Pharmaceutical Executives Including CFO Lu Hongbin Plan to Reduce Shareholdings

CSPC Pharm Begins Phase III Breast Cancer Drug Trial

MT Newswires Live

Hubei Tycoon Ai Luming Detained: Who Is Hurt by Tiangan Asset Management's 3.5 Billion Yuan Debt?

FOSUN PHARMA Spends HK$1.2695 Million to Buy Back 72,000 Shares on September 24

CSPC Pharmaceutical - Pharma Initiates Phase Iii Trial of Hb1801 for Advanced Breast Cancer in China

THOMSON REUTERS

Hong Kong Stocks Close Lower as Oil Shares Rise Against the Trend, While Materials, Pharma and Tech Stocks Face Pressure

GenFleet Therapeutics-B Director Tao Sha Steps Down from Non-Executive Role

Sinopharm Group Stock Sheds 1.0% in Hong Kong

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BK1515/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":887.02344,"timestamp":1791446895366,"preClose":914.24426,"halted":0,"volume":327704239,"delay":0,"changeRate":-0.029774,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-27.220825,"latestTime":"10-08 16:00:00","open":914.5563,"high":930.2323,"low":882.49786,"amount":2637023190,"amplitude":0.052212,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791509400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1791423000000,1791432000000],[1791435600000,1791446400000]],"pbRate":1.386435,"peRate":17.966934,"turnoverRate":0.004295,"increases":2,"decrements":15,"flats":0,"marketCap":600048859328,"floatMarketCap":495413002688},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":930.2323,"amplitude":0.052212,"preClose":914.24426,"low":882.49786,"pbRate":"1.386435","latestPrice":887.02344,"volume":327704239,"delay":0,"open":914.5563,"prevYearClose":1190.107,"prevWeekClose":903.801,"prevMonthClose":925.469,"prevQuarterClose":925.469,"fiveDayClose":925.469,"twentyDayClose":912.778,"sixtyDayClose":917.488,"secType":"PLATE","market":"HK","turnoverRate":0.004295,"peRate":17.966934,"marketCap":600048859328,"floatMarketCap":495413002688,"timestamp":1791446895366,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":3,"down":14,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670808280","title":"Sino Biopharmaceutical Stock Slides 1.3% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670808280","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670808280?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:33","pubTimestamp":1790584380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 1.3% to 5.50 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 24642.51.This was the stock's fifth consecutive day of losses.Sino Biopharmaceutical Ltd. closed 36% short of its 52-week high of HK$8.54, which the company reached Oct. 8.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 0.6% and Amgen Inc. remained unchanged.Trading volume totaled 57.5 million shares, compared to the 50-day average of 82.2 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK4534","LU0868494617.USD","LU0058720904.USD","01177","LU0109394709.USD","BK4139","IE00B2B36J28.USD","IE00BZ08YR35.GBP","BK4585","LU1057294990.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","BK4599","BK4581","LU1983299246.USD","BK1515","AMGN","SG9999001440.SGD","BK4588","IE0002141913.USD","LU1061106388.HKD","IE00BZ08YT58.USD","LU2468319806.SGD","TBXU","IE00BZ08YS42.EUR","BK4533","LU1023059063.AUD","BK1521","HK0000165453.HKD","BK1589","LU2112291526.USD","LU2089984988.USD","PJP","BIB","IBB","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU2242646821.SGD","LU0122379950.USD","LU1571399168.USD","IBBQ","IE0009355771.USD","LU0289739699.SGD","LU0889565916.HKD","91335","PBE","LU2242652126.USD","IE00BJJMRZ35.SGD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670228080","title":"JD Health International Stock Rises 1.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2670228080","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670228080?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:33","pubTimestamp":1790584380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. rallied 1.3% to 35.54 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 24642.51.The stock's rise snapped a four-day losing streak.JD Health International Inc. closed 50% short of its 52-week high of HK$71.70, which the company achieved Jan. 15.Trading volume totaled 8.2 million shares, compared to the 50-day average of 8.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1571","SGXZ86797644.SGD","BK1247","LU0456827905.SGD","86618","BK1589","SGXZ62798434.SGD","06618","BK1583","BK1615","LU0051755006.USD","BK1142","BK1591","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132272624","title":"Healthcare Shows Resilience! Pharma ETF Huabao (562050) Rises Against the Market, Livzon Pharmaceutical Group Hits Limit Up! Medical Devices Show Localized Strength, Mindray and United Imaging Advance Together","url":"https://stock-news.laohu8.com/highlight/detail?id=1132272624","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132272624?lang=en_us&edition=fundamental","pubTime":"2026-09-28 13:22","pubTimestamp":1790572929,"startTime":"0","endTime":"0","summary":"On the first trading day after the Mid-Autumn Festival (September 28), A-shares underwent a deep correction, with the Shanghai Composite Index falling nearly 2% at one point. Pharmaceutical assets...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","000513","BK1583","BK1574","AGNG","159883","BK1515","BK0187","562050","RSPH","BK1100","159938","09996","LGHT","09939","BK0239","IEIH","HART","LNGR","PTH","MEDX","GDOC","BK0188","MDEV","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108038702","title":"Fosun Pharma Spends HK$1.0805 Million to Repurchase 62,000 Shares on September 25","url":"https://stock-news.laohu8.com/highlight/detail?id=1108038702","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108038702?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:30","pubTimestamp":1790555421,"startTime":"0","endTime":"0","summary":"Fosun Pharma (02196) issued an announcement stating that on September 25, 2026, the company spent HK$1.0805 million to repurchase 62,000 shares.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1593","02196","BK0175","BK0239","BK0183","BK0028","600196","BK0196","BK0188","BK0012","BK1515","BK0096","BK0060","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191497499","title":"Lazard Asset Management LLC Trims 738,800 Shares in Sinopharm (01099) at Approximately HK$15.1 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1191497499","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191497499?lang=en_us&edition=fundamental","pubTime":"2026-09-27 19:08","pubTimestamp":1790507292,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on September 21, Lazard Asset Management LLC reduced its holdings in Sinopharm (01099) by 738,800 shares at a price of HK$15.1035 per...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","LU1115378108.SGD","BK1500","01099","BK1515","EWH","LU0640798160.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164509239","title":"FMR LLC Trims Sinopharm Stake by 732,400 Shares at About HK$15.01 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1164509239","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164509239?lang=en_us&edition=fundamental","pubTime":"2026-09-27 19:08","pubTimestamp":1790507291,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on September 21, FMR LLC reduced its holdings in Sinopharm (SEHK: 01099) by 732,400 shares at a price of HK$15.0147 per share, for a...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","LU1115378108.SGD","BK1515","01099","BK1197","LU0640798160.USD","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670446469","title":"JD Health International Stock Sheds 2.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2670446469","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670446469?lang=en_us&edition=fundamental","pubTime":"2026-09-25 16:30","pubTimestamp":1790325000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. slid 2.0% to 35.08 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.0% to 24510.09.This was the stock's fourth consecutive day of losses.JD Health International Inc. closed 51% short of its 52-week high of HK$71.70, which the company achieved Jan. 15.Trading volume totaled 5.6 million shares, compared to the 50-day average of 8.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1142","BK1571","BK1515","BK1589","BK1591","SGXZ86797644.SGD","SGXZ62798434.SGD","BK1583","BK1615","LU0051755006.USD","06618","BK1247","86618","LU0456827905.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171106151","title":"Regulator Clarifies Insurers' Hong Kong Stock Connect ETF Investment Rules; Crealights' Southbound Stake Rises to 4.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1171106151","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171106151?lang=en_us&edition=fundamental","pubTime":"2026-09-25 08:12","pubTimestamp":1790295146,"startTime":"0","endTime":"0","summary":"Several insurers recently received a letter clarifying the regulatory scope for insurance funds investing in Hong Kong Stock Connect ETFs. The document specifies that insurance institutions eligible...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1230","IE0032431581.USD","LU1951186391.HKD","BK1515","BK1191","LU0140636845.USD","LU1328277881.USD","IE00B5MMRT66.SGD","LU1226287529.USD","BK1537","LU1226288253.USD","IE00B3M56506.USD","LU1807302812.USD","LU0072913022.USD","LU2097828557.USD","SG9999012736.USD","LU0320764599.SGD","BK1589","BK1546","01133","BK1205","LU0501845795.SGD","IE00BZ08YR35.GBP","BK1584","BK1521","LU2257852520.SGD","LU0287142896.SGD","LU1226287792.SGD","LU0169518387.USD","03692","HK0000165453.HKD","LU1008478684.HKD","LU2097828631.EUR","LU3063872942.SGD","IE0008368742.USD","03933","02628","LU1808992512.USD","BK4585","LU0173614495.USD","LU0211977185.USD","SG9999003461.SGD","IE00BZ08YS42.EUR","LU0314109678.HKD","LU0880133367.SGD","IE0008369823.USD","SG9999004220.SGD","LU2097828805.USD","LU0067412154.USD","LU2097828474.EUR","LU1226288170.HKD","BK1184","BK4588","LU1813983027.USD","IE00B031HY20.USD","00659","LU1993786604.SGD","LU0708995583.HKD","BK4550","KURE","LU1206782309.USD","FDN","LU1226287875.USD","SG9999012744.USD","01191","HK0000286598.CNH","BK1550","SG9999012710.SGD","LU0588546209.SGD","LU0531971595.HKD","FLHK","SG9999012728.SGD","LU0164865239.USD","LU2039709279.SGD","LU1960683339.HKD","LU1152091754.HKD","BK1170","BK1147","LU0326950275.SGD","KCAI","LU0039217434.USD","VXUS","LU0315179316.USD","LU0307460666.USD","LU1152091168.USD","LU0871576103.HKD","BK1583","01093","IE00B543WZ88.USD","LU1046422090.SGD","LU2097828714.EUR","LU0052750758.USD","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669558491","title":"CSPC Pharmaceutical Says Phase III Trial of Becotatug Achieves Positive Topline Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2669558491","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669558491?lang=en_us&edition=fundamental","pubTime":"2026-09-24 23:01","pubTimestamp":1790262116,"startTime":"0","endTime":"0","summary":"BRIEF-CSPC Pharmaceutical Says Phase III Trial Of Becotatug Achieves Positive Topline ResultsSept 24 (Reuters)-CSPC PHARMACEUTICAL GROUP LIMITED1093.HK:PHASE III TRIAL OF BECOTATUG (JMT101) WITH OSIMERTINIB ACHIEVES POSITIVE TOPLINE RESULTSFurther company coverage:1093.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G0DK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328277881.USD","IE00BZ08YS42.EUR","LU1226288253.USD","LU1960683339.HKD","LU0315179316.USD","BK1191","BK1515","LU1226287529.USD","IE00B543WZ88.USD","IE00B031HY20.USD","IE00B5MMRT66.SGD","IE0008369823.USD","LU1226288170.HKD","LU1951186391.HKD","LU1807302812.USD","LU0140636845.USD","HK0000165453.HKD","SG9999004220.SGD","LU0314109678.HKD","LU1152091754.HKD","LU1813983027.USD","LU1993786604.SGD","LU1226287875.USD","01093","LU2039709279.SGD","IE00BZ08YT58.USD","LU1152091168.USD","LU1008478684.HKD","BK1521","LU0072913022.USD","LU0880133367.SGD","LU0501845795.SGD","LU0326950275.SGD","IE00BZ08YR35.GBP","IE0008368742.USD","LU1226287792.SGD","KURE","LU0067412154.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669498067","title":"CSPC Pharma's Phase III Trial of Lung Cancer Drug Combo Achieves Positive Topline Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2669498067","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669498067?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:55","pubTimestamp":1790254529,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group's  phase III trial of Becotatug in combination with osimertinib met its primary endpoint at a pre-specified interim analysis and achieved positive topline results.The drug combination was being tested for the first-line treatment of locally advanced or metastatic non-small cell lung cancer.Compared with platinum-based chemotherapy in combination with pemetrexed, the treatment combination significantly prolonged the progression-free survival of patients and showed a trend of benefit in overall survival.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1813983027.USD","LU1226288253.USD","LU0314109678.HKD","01093","LU1328277881.USD","BK1521","IE00BZ08YT58.USD","LU1008478684.HKD","LU0067412154.USD","IE00BZ08YR35.GBP","LU1226287529.USD","LU1993786604.SGD","KURE","LU0326950275.SGD","IE0008369823.USD","LU0501845795.SGD","LU1807302812.USD","LU1960683339.HKD","LU1226288170.HKD","LU1226287875.USD","IE00B031HY20.USD","LU1152091168.USD","IE00BZ08YS42.EUR","SG9999004220.SGD","LU1226287792.SGD","IE00B5MMRT66.SGD","LU0880133367.SGD","BK1515","LU1951186391.HKD","IE00B543WZ88.USD","LU0072913022.USD","LU1152091754.HKD","LU0140636845.USD","BK1191","LU2039709279.SGD","IE0008368742.USD","HK0000165453.HKD","LU0315179316.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183769643","title":"CSPC Pharma's JMT101 Combined with Osimertinib Achieves Positive Topline Results in Phase III Trial for First-Line Treatment of EGFR ex20ins NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=1183769643","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183769643?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:28","pubTimestamp":1790252894,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that the Phase III clinical trial of its developed becotatug (JMT101) in combination with osimertinib for the first-line treatment of locally advanced or metastatic...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1813983027.USD","LU1226288253.USD","PSYK","LU0314109678.HKD","01093","LU1328277881.USD","BK1521","IE00BZ08YT58.USD","LU1008478684.HKD","LU0067412154.USD","IE00BZ08YR35.GBP","LU1226287529.USD","LU1993786604.SGD","BMED","KURE","LU0326950275.SGD","IE0008369823.USD","IBBQ","LU0501845795.SGD","LU1807302812.USD","LU1960683339.HKD","MDTX","LU1226288170.HKD","LU1226287875.USD","IE00B031HY20.USD","LU1152091168.USD","IE00BZ08YS42.EUR","SG9999004220.SGD","LU1226287792.SGD","IE00B5MMRT66.SGD","LU0880133367.SGD","BK1515","LU1951186391.HKD","IE00B543WZ88.USD","LU0072913022.USD","LU1152091754.HKD","LU0140636845.USD","BK1191","IBBJ","LU2039709279.SGD","IE0008368742.USD","HK0000165453.HKD","LU0315179316.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669460157","title":"CSPC Pharmaceutical - Phase Iii Trial of Becotatug (Jmt101) with Osimertinib Achieves Positive Topline Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2669460157","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669460157?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:08","pubTimestamp":1790251730,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G0DK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B031HY20.USD","LU0067412154.USD","KURE","LU0880133367.SGD","LU1951186391.HKD","LU1807302812.USD","LU2039709279.SGD","IE00BZ08YS42.EUR","BK1191","IE0008369823.USD","LU1008478684.HKD","LU1328277881.USD","IE0008368742.USD","BK1515","LU0326950275.SGD","LU1226287529.USD","LU0072913022.USD","LU1960683339.HKD","SG9999004220.SGD","IE00B543WZ88.USD","LU1152091754.HKD","IE00BZ08YT58.USD","LU1226288170.HKD","LU0314109678.HKD","LU0501845795.SGD","LU0315179316.USD","LU1226287792.SGD","LU1226288253.USD","LU1993786604.SGD","IE00BZ08YR35.GBP","LU1226287875.USD","IE00B5MMRT66.SGD","LU0140636845.USD","LU1152091168.USD","01093","LU1813983027.USD","BK1521","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132416534","title":"Dizal Pharmaceutical Executives Including CFO Lu Hongbin Plan to Reduce Shareholdings","url":"https://stock-news.laohu8.com/highlight/detail?id=1132416534","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132416534?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:01","pubTimestamp":1790251288,"startTime":"0","endTime":"0","summary":"Dizal Pharmaceutical has released a new announcement stating that five senior executives, including Chief Financial Officer Lu Hongbin, Deputy General Manager Chen Suqin, QINGBEIZENG, HONCHUNGTSUI,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1574","BK1161","09939","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669246984","title":"CSPC Pharm Begins Phase III Breast Cancer Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669246984","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669246984?lang=en_us&edition=fundamental","pubTime":"2026-09-24 17:42","pubTimestamp":1790242928,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group (HKG:1093) officially initiated a phase III trial of docetaxel for injection at the first centre in China, according to a Thursday bourse filing.The study will evaluate the safety and efficacy of the drug in patients with advanced breast cancer, the filing said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1226287792.SGD","IE0008369823.USD","IE00BZ08YR35.GBP","LU0880133367.SGD","LU1152091754.HKD","IE00BZ08YS42.EUR","LU0315179316.USD","LU1226288170.HKD","LU0501845795.SGD","IE0008368742.USD","LU0140636845.USD","LU1328277881.USD","BK1191","IE00B031HY20.USD","LU1951186391.HKD","LU1226287875.USD","BK1521","LU1960683339.HKD","LU1226287529.USD","HK0000165453.HKD","KURE","LU1813983027.USD","LU1807302812.USD","IE00BZ08YT58.USD","SG9999004220.SGD","LU1226288253.USD","LU1152091168.USD","LU0072913022.USD","LU0326950275.SGD","BK1515","LU1008478684.HKD","LU0314109678.HKD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","01093","LU0067412154.USD","LU2039709279.SGD","LU1993786604.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157621104","title":"Hubei Tycoon Ai Luming Detained: Who Is Hurt by Tiangan Asset Management's 3.5 Billion Yuan Debt?","url":"https://stock-news.laohu8.com/highlight/detail?id=1157621104","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157621104?lang=en_us&edition=fundamental","pubTime":"2026-09-24 17:21","pubTimestamp":1790241693,"startTime":"0","endTime":"0","summary":"On the evening of September 18, a public announcement from Wuhan Sante Cableway Group Co.,Ltd. (002159.SZ) pushed the \"Dangdai Group\" and its founder Ai Luming back into the spotlight once again.The...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600079","BK0102","BK0070","BK1515","BK0040","AMC","BK1161","BK0241","09939","BK4108","BK0096","BK0188","002159","BK0185","BK0028","BK4547","BK1574","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124005011","title":"FOSUN PHARMA Spends HK$1.2695 Million to Buy Back 72,000 Shares on September 24","url":"https://stock-news.laohu8.com/highlight/detail?id=1124005011","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124005011?lang=en_us&edition=fundamental","pubTime":"2026-09-24 17:18","pubTimestamp":1790241516,"startTime":"0","endTime":"0","summary":"FOSUN PHARMA (02196) has announced that on September 24, 2026, it spent HK$1.2695 million to repurchase 72,000 shares.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK1593","BK0028","BK0183","BK0060","BK0096","BK0188","600196","BK0196","BK1191","02196","BK1515","BK0175","BK0012","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669465671","title":"CSPC Pharmaceutical - Pharma Initiates Phase Iii Trial of Hb1801 for Advanced Breast Cancer in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2669465671","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669465671?lang=en_us&edition=fundamental","pubTime":"2026-09-24 17:01","pubTimestamp":1790240462,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G0P5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0501845795.SGD","BK1191","LU1813983027.USD","LU1951186391.HKD","IE00B031HY20.USD","LU1328277881.USD","LU1960683339.HKD","LU1993786604.SGD","LU1152091754.HKD","LU1226287875.USD","LU1008478684.HKD","LU0072913022.USD","IE0008369823.USD","SG9999004220.SGD","LU2039709279.SGD","IE0008368742.USD","LU1226288170.HKD","LU0880133367.SGD","LU0326950275.SGD","LU1226287792.SGD","01093","BK1521","IE00BZ08YS42.EUR","IE00B543WZ88.USD","LU0315179316.USD","BK1515","LU1807302812.USD","LU0067412154.USD","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","LU1226287529.USD","HK0000165453.HKD","KURE","LU0314109678.HKD","IE00B5MMRT66.SGD","LU0140636845.USD","LU1226288253.USD","LU1152091168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122594185","title":"Hong Kong Stocks Close Lower as Oil Shares Rise Against the Trend, While Materials, Pharma and Tech Stocks Face Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1122594185","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122594185?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:38","pubTimestamp":1790239108,"startTime":"0","endTime":"0","summary":"Hong Kong stocks ended lower on Tuesday as three major indices struggled, pressured by rebounding oil prices amid Iran's tough stance and unexpectedly strong U.S. PMI data that triggered a fresh...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828557.USD","IEO","LU0588545730.USD","09939","83115","LU0348735423.USD","LU2097828474.EUR","USL","IE00B19Z5X02.USD","BK4570","GUSH","DIG","KCAI","LU0287142896.SGD","LU1675838814.USD","LU0293314216.USD","BK1198","BK1515","MCHmain","LU0348805143.USD","02800","LU0314109678.HKD","LU1770034418.SGD","00857","SG9999006597.SGD","LU1634259557.SGD","82800","VDE","LU1188198961.HKD","LU1115378108.SGD","513600","LU0359201612.USD","LU0634319403.HKD","IE00BWDBJ730.SGD","OIH","SGXZ62798434.SGD","LU0211977185.USD","03330","LU0640798160.USD","LU1328277881.USD","LU0862451753.SGD","SG9999001093.SGD","LU0052750758.USD","LU0327786744.USD","LU0708995583.HKD","LU0865486749.SGD","BK1574","SG9999003461.SGD","LU2097828714.EUR","BK4588","LU1303224171.USD","HHImain","LU1720050803.USD","LU0348827113.USD","BK1544","03986","07300","BK4585","LU1719994722.HKD","LU1023057109.AUD","IE00BQJZWZ67.USD","BK1592","LU0469268626.HKD","LU0359201885.HKD","09690","LU2039709279.SGD","LU1961090484.USD","LU2097828631.EUR","BK1158","DBC","LU0463099449.HKD","BK1226","DBE","PXJ","LU2293587155.HKD","LU1785774172.SGD","LU2097828805.USD","VXUS","LU0326950275.SGD","HSI","LU0588545904.SGD","LU0181495838.USD","XLE","LU0140636845.USD","03115","SGXZ86797644.SGD","LU1497733631.SGD","LU0890818403.SGD","FTXN","OILT","LU2328871848.SGD","LU0405327494.USD","LU1048588211.SGD","159876","OILK","DRIP","LU0348784397.USD","LU1794554557.SGD","LU0307460666.USD","09115","LU0173614495.USD","LU0862451837.USD","LU1969619763.USD","LU0417516738.SGD","159019","LU0588545490.SGD","LU0315178854.USD","LU0417516902.SGD","XES","ERX","03037","LU2399975544.HKD","LU0561508036.HKD","LU1831875114.USD","LU1522347837.USD","WTIU","OILU","BK1163","03419","LU0588546209.SGD","07500","BK1169","BK1528","LU1497733557.USD","09969","LU0348783233.USD","DRLL","LU0540923850.HKD","IXC","LU1497734951.SGD","SG9999014674.SGD","LU0244354667.USD","LU0972618739.USD","LU0572944931.SGD","USE","159938","LU1282651048.USD","PXE","HSImain","SG9999004220.SGD","07200","02726","LU0072462343.USD","LU0675040207.SGD","LU0320764599.SGD","USOI","MHImain","LU0348783662.USD","LU1251922891.USD","LU0405327148.USD","LU0417516571.SGD","LU1808992512.USD","LU0441854154.USD","BNO","02833","LU1224444064.USD","BK1161","LU0611395673.USD","LU0348825331.USD","BK1521","LU1282651121.HKD","XOP","LU0359202008.SGD","LU1813983027.USD","LU1634259391.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192159357","title":"GenFleet Therapeutics-B Director Tao Sha Steps Down from Non-Executive Role","url":"https://stock-news.laohu8.com/highlight/detail?id=1192159357","media":"Stock News","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192159357?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:36","pubTimestamp":1790238979,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics-B (02595) has announced that Ms. Tao Sha has resigned from her position as a non-executive director due to personal work commitments.The resignation takes effect from September 24, 2026, according to the company's filing.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","BK1574","09939","159938","02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669463557","title":"Sinopharm Group Stock Sheds 1.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2669463557","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669463557?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:32","pubTimestamp":1790238720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slid 1.0% to 14.91 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.3% to 24761.13.Sinopharm Group Co. Ltd. closed 33% below its 52-week high of HK$22.34, which the company reached Feb. 25.Despite its losses, the stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 1.5%.Trading volume totaled 3.3 million shares, compared to the 50-day average of 4.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK1593","01099","LU0640798160.USD","BK1500","BK0175","BK0012","BK0183","BK4175","BK1197","LU1115378108.SGD","BK1515","SHTDY","BK0239","BK1191","BK0187","BK0028","BK0096","02196","BK0060","BK0196","600196"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":6,"totalSize":126,"code":"91000000","status":"200"}]}}